FREE ENDURING MATERIAL ACTIVITY
Release date: December 12, 2016
Valid through: December 12, 2019
Re-reviewed December 12, 2019; valid through December 12, 2020.
Format: Didactic, PowerPoint,
Osteoarthritis (OA) and rheumatoid arthritis (RA) in women
cause chronic pain and are incompletely understood. Both involve both
nociceptive and non-nociceptive mechanisms, including neuropathic mechanisms
due to peripheral inflammation and central sensitization [1, 2]. Managing pain
from these chronic conditions in women requires the clinician to balance the
need for effective analgesia against safety risks associated with analgesic
agents. Not treating pain is not an option since chronic pain itself is
associated with considerable mortality [3-5], and effective analgesia is viewed
as a fundamental human right [6-8]. Prevailing guidelines for arthritis-related
pain do not differentiate between nociceptive and non-nociceptive pain,
sometimes leading to recommendations that do not fully address the nature of
pain. Despite a wealth of analgesic options, managing moderate to severe
chronic pain as a women’s issue remains clinically challenging for several
reasons. This webinar will review best practices for effective treatment and
management of rheumatoid arthritis conditions in women, and will discuss when
combination therapy may be more appropriate to manage the different pain
Ellen W. K. Rosenquist, MD
Dr. Rosenquist completed her anesthesiology residency at Beth Israel Deaconess Medical Center/Harvard Medical School and her pain medicine fellowship at the University of Pennsylvania. She is board certified in anesthesiology and pain medicine. She also completed training in medical acupuncture through the Helms Medical Institute and is certified in medical acupuncture. She is currently an assistant professor at the Cleveland Clinic Lerner College of Medicine of Case Western University.
: Following this session,
attendees will be better able to:
- Review best
practices for effective treatment and management of rheumatoid arthritis conditions
complementary and alternative treatment options which have been shown to be of
therapeutic value for reducing pain in patients with Rheumatoid Arthritis and
other arthritic conditions.
- Describe the
characteristics associated with osteoarthritis.
disease-modifying anti-rheumatic drugs.
Members of the primary care team who provide health services and
education to women throughout the lifespan, including physicians, nurse
practitioners, physician assistants, nurses, and support staff who practice in
obstetrics/gynecology, family medicine, pain medicine, rheumatology, internal
medicine, and related settings.
|Continuing Education: The AAPM will provide an enduring internet activity (webinar) titled “
Management for Women with Rheumatoid and Other Arthritic Conditions
and will offer continuing medical education (CME) for physicians. Successful
completion requires that participants register for the webinar and complete a
pre-test, attend and participate, and complete a post-test and an online
evaluation. Participants will receive their CME certificates after they
submit their evaluations online.
The American Academy of Pain Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
American Academy of Pain Medicine designates this enduring material for a
maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the
credit commensurate with the extent of their participation in the activity.
Funding for this course was made possible by an educational grant
from Pfizer via the Association of Reproductive Health Professionals. Funder did
not influence nor have control over the development or delivery of
Disclaimer:The material presented in
this activity represents the opinion of the authors/faculty and not
necessarily the view of the American Academy of Pain Medicine.
Instructions for Course
This live activity will consist of a
didactic presentation accompanied by PowerPoint slides, followed by a
question-and-answer session. There is no fee to participate. The learner is
required to respond to the pre-test question(s) before beginning the
presentation. Since it is not possible to fail a pre-test, upon submission,
"passed" will appear on your screen. This is not an indication that
questions were answered correctly.
1) You are required to view the entire presentation.
2) Learners must answer all post-test questions to proceed to the activity
evaluation. 3) Learners must receive at least an 80% passing score.
4) An evaluation must be completed prior to receipt of your certificate.
5) After completing the post-test and activity evaluation(s), a statement of
credit will be generated and printed on your own at your convenience.
For additional assistance, please contact the American Academy of Pain
Medicine, 8735 W. Higgins Road, Suite 300, Chicago, IL 60631, 847-375-4731.
If you need further assistance with software requirements please contact
Internet CME Policy
In regard to its CME programming and initiatives, The American Academy of
Pain Medicine is committed to protecting the privacy of its members and
customers. AAPM maintains its website as an information resource and service
for physicians and other health care professionals. AAPM ensures that all
personal and credit card information (if applicable) is kept confidential when participating
in any Internet CME activity and that personal information will not be shared
with any person/entity outside of AAPM. AAPM will ask for only that
information necessary to provide the service(s) requested.
It is the policy of AAPM to plan and
implement educational activities in accordance with ACCME’s Essential Areas
and Elements to ensure balance, independence, objectivity, and scientific
rigor. All program faculty and planners are required to disclose all
financial relationships they may have or have had within the last 12 months
with commercial interests whose products or services are related to the
subject matter of the presentation. Any real or apparent conflicts of
interest will be resolved prior to the presentation. All confirmed faculty
disclosure information will be made available to participants prior to the
activity. Faculty will also be expected to disclose this information to the
audience both verbally and in print (slide presentation) at the beginning of
Disclosure of Unlabeled Use:
This educational activity may contain
discussion of published and/or investigational uses of agents that are not
indicated by the FDA. The American Academy of Pain Medicine does not
recommend the use of any agent outside of the labeled indications. The
opinions expressed in the educational activity are those of the faculty and
do not necessarily represent the views of any organization associated with
this activity. Please refer to the official prescribing information for each
product for discussion of approved indications, contraindications, and
Disclosure information appears below.
Planners and Faculty:
Jianguo Cheng, MD, PhD, FIPP
Planner, Course Reviewer
Professor of Anesthesiology
Vice President for Scientific Affairs, American Academy of Pain
Director, Cleveland Clinic Pain Medicine Fellowship Program
Departments of Pain Management and Neurosciences
Cleveland Clinic Anesthesiology Institute and Lerner Research
*No relevant financial
Larry C. Driver, MD
Chair, AAPM Professional Education and CME Oversight Committee
The University of Texas M.D. Anderson Cancer Center
*No relevant financial relationships
Planner, ARHP Staff
Education Program Manager
Association of Reproductive Health Professionals
*No relevant financial relationships
Ellen W.K. Rosenquist, MD
Assistant Professor of
The Cleveland Clinic Lerner College of Medicine of Case Western Reserve
The Cleveland Clinic
*UpToDate (Author; Royalties); KURE (Board of Directors –
Spouse; Stockholder – Spouse)
Jennifer Westlund, MSW
Planner, AAPM Staff
Director of Education, American
Academy of Pain Medicine
*No relevant financial relationships
Please note: The disclosure
information stated above were relevant financial relationships based upon the
12-month reporting period prior to the live education activity date of December